Resmed (RMD) Treasury Shares (2010 - 2026)

Resmed has reported Treasury Shares for 17 years, with the latest figure at $2.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 30.59% year-over-year to $2.6 billion; the trailing twelve-month figure through Mar 2026 stood at $2.6 billion (up 30.59% YoY), and the FY2025 full-year result was $2.1 billion, up 16.92% from the prior year.
• Treasury Shares for Q1 2026 stood at $2.6 billion, up from $2.4 billion in the prior quarter.
• The five-year high for Treasury Shares was $45.8 million in Q1 2026, with the low at $307000.0 in Q4 2024.
• Historically, Treasury Shares has averaged $35.3 million across 5 years, with a median of $41.8 million in 2022.
• Annual changes were most pronounced in 2022 — Treasury Shares changed 0.0% — and 2026, when it surged 30.59%.
• Resmed's Treasury Shares stood at $1.6 billion in 2022, then advanced by 3.08% to $1.7 billion in 2023, then grew by 13.45% to $1.9 billion in 2024, then grew by 26.45% to $2.4 billion in 2025, then gained by 7.36% to $2.6 billion in 2026.
• The last three Treasury Shares figures came in at $2.6 billion (Q1 2026), $2.4 billion (Q4 2025), and $2.2 billion (Q3 2025), per Business Quant data.